Table 2.
Experiment | Dose of SV1610 (Dam−)* | Challenge dose of SL1344 (wt)† | No. dead mice/ inoculated mice |
---|---|---|---|
1 | — | 2.8 × 103 | 1/5 |
— | 2.8 × 104 | 1/5 | |
— | 2.8 × 105 | 4/5 | |
2 | 2.5 × 106 | 1.2 × 106 | 1/4 |
2.5 × 107 | 1.2 × 106 | 1/4 | |
2.5 × 108 | 1.2 × 106 | 0/4 | |
3 | 7 × 106 | 9.7 × 106 | 0/5 |
7 × 107 | 9.7 × 106 | 1/5 | |
7 × 108 | 9.7 × 106 | 0/5 | |
89 (i.p.) | 9.7 × 106 | 0/5 | |
890 (i.p.) | 9.7 × 106 | 0/5 | |
8.900 (i.p.) | 9.7 × 106 | 1/5 |
Inoculations were done by the oral route, except when indicated i.p. After 4 wk, all Dam− infected mice survived the doses of bacteria indicated.
All inoculations were done by the oral route. In experiments 2 and 3, challenges with the wild-type strain were done 4 wk after the inoculation with the Dam− mutant. Mouse survival was recorded for 4 additional weeks.